Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder

NCT02909959 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Autism Spectrum Disorder
Autistic Disorder
Neurodevelopmental Disorder
Childhood Developmental Disorders, Pervasive

Interventions

DRUG: Sulforaphane
DRUG: Placebo

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]